Marpai (MRAI) Competitors $0.77 -0.13 (-14.42%) (As of 11/5/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MRAI vs. XGN, CCM, BNR, ATIP, TOI, RNLX, OPGN, PMD, BRTX, and CMAXShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Exagen (XGN), Concord Medical Services (CCM), Burning Rock Biotech (BNR), ATI Physical Therapy (ATIP), Oncology Institute (TOI), Renalytix (RNLX), OpGen (OPGN), Psychemedics (PMD), BioRestorative Therapies (BRTX), and CareMax (CMAX). These companies are all part of the "healthcare" industry. Marpai vs. Exagen Concord Medical Services Burning Rock Biotech ATI Physical Therapy Oncology Institute Renalytix OpGen Psychemedics BioRestorative Therapies CareMax Exagen (NASDAQ:XGN) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Is XGN or MRAI more profitable? Exagen has a net margin of -30.56% compared to Marpai's net margin of -92.76%. Marpai's return on equity of 0.00% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-30.56% -78.90% -31.77% Marpai -92.76%N/A -99.32% Do analysts prefer XGN or MRAI? Exagen presently has a consensus target price of $7.00, indicating a potential upside of 184.55%. Marpai has a consensus target price of $6.00, indicating a potential upside of 677.71%. Given Marpai's higher possible upside, analysts clearly believe Marpai is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of XGN or MRAI? 75.3% of Exagen shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 26.1% of Exagen shares are held by company insiders. Comparatively, 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings & valuation, XGN or MRAI? Exagen has higher revenue and earnings than Marpai. Exagen is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$52.55M0.81-$23.69M-$0.97-2.54Marpai$37.15M0.29-$28.75M-$3.32-0.23 Does the media prefer XGN or MRAI? In the previous week, Exagen's average media sentiment score of 0.00 equaled Marpai'saverage media sentiment score. Company Overall Sentiment Exagen Neutral Marpai Neutral Does the MarketBeat Community prefer XGN or MRAI? Exagen received 18 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 54.05% of users gave Exagen an outperform vote. CompanyUnderperformOutperformExagenOutperform Votes2054.05% Underperform Votes1745.95% MarpaiOutperform Votes266.67% Underperform Votes133.33% Which has more risk & volatility, XGN or MRAI? Exagen has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, Marpai has a beta of 4.69, suggesting that its stock price is 369% more volatile than the S&P 500. SummaryExagen beats Marpai on 9 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$10.60M$1.98B$6.64B$8.58BDividend YieldN/A2.24%2.98%4.03%P/E Ratio-0.2319.7042.1416.00Price / Sales0.296.11242.7398.09Price / CashN/A11.7321.5431.48Price / Book-0.453.504.724.67Net Income-$28.75M$69.56M$118.16M$223.25M7 Day Performance-4.75%-0.97%0.27%0.41%1 Month Performance28.58%-10.85%4.96%4.69%1 Year Performance83.69%-8.25%22.78%27.26% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$0.77-14.4%$6.00+677.7%+114.3%$10.60M$37.15M-0.23150Gap DownXGNExagen4.1905 of 5 stars$2.47-3.9%$7.00+183.4%+46.2%$42.94M$56.66M-2.55220Upcoming EarningsCCMConcord Medical Services1.412 of 5 stars$7.80-1.1%N/A-29.7%$33.85M$75.69M0.00970News CoverageBNRBurning Rock Biotech0.2747 of 5 stars$2.71-3.2%N/A-72.3%$27.75M$75.70M-0.561,390Gap DownATIPATI Physical Therapy1.2696 of 5 stars$5.15-6.4%N/A-33.4%$22.64M$729.33M-0.385,600News CoverageTrading HaltedHigh Trading VolumeTOIOncology Institute2.2956 of 5 stars$0.28-6.7%$2.50+792.9%-86.1%$21.14M$361.07M-0.35660Gap DownRNLXRenalytix1.2329 of 5 stars$0.21+5.7%$3.00+1,348.6%-80.1%$17.18M$2.29M-0.53100Upcoming EarningsGap UpOPGNOpGenN/A$1.75-3.3%N/A-75.9%$14.63M$3.42M0.00100Upcoming EarningsGap DownPMDPsychemedicsN/A$2.32flatN/A-1.3%$13.67M$22.10M-2.97140Positive NewsBRTXBioRestorative Therapies3.7231 of 5 stars$1.50-3.8%$18.00+1,100.0%-21.5%$10.38M$150,000.00-0.747Upcoming EarningsNews CoverageGap UpCMAXCareMax3.1226 of 5 stars$1.97-4.4%$45.00+2,184.3%-96.7%$7.52M$784.55M-0.011,450News CoverageGap Up Related Companies and Tools Related Companies Exagen Competitors Concord Medical Services Competitors Burning Rock Biotech Competitors ATI Physical Therapy Competitors Oncology Institute Competitors Renalytix Competitors OpGen Competitors Psychemedics Competitors BioRestorative Therapies Competitors CareMax Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRAI) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRAI Stock Alerts